Condition: Gastric Cancer · Sponsor: Nanfang Hospital, Southern Medical University
Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).
This description comes directly from the study's public registry record.
Xinhua Chen, Ph.D · 8615626452302 · xinhuachen@163.com
Tian Lin, Ph.D · 8613560035029
Always discuss trial participation with your own doctor first.
| Nanfang Hospital | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05494086